Category Archives: FDA

Actavis 1000% drug price hike: a case for healthcare reform

Update September 21, 2015- The Healthcare Channel was the first to report in 2009 on the business strategy of acquiring cheap generic drugs, cornering the market, then raising

Posted in - Biotech, - Generics, - Opinion, - Policy, CMS, Congress, FDA, Infectious disease | Leave a comment

The newly approved Edwards Lifesciences Sapien 3 aortic valve

July 5, 2015- Interviewed by Steven E. Greer, MD We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, UCLA | Leave a comment

The deadly risks of TAVR being downplayed to patients by hospitals

January 18, 2015- By Steven E. Greer, MD On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to

Posted in - Medical Devices, - Opinion, Cardiac surgery, Cardiology, FDA | Leave a comment

How pain pills almost killed my mother after elective knee surgery

May 21, 2014- By Steven E. Greer, MD My mother is in her 70’s and in good health except for debilitating knee arthritis. After considerable

Posted in - Opinion, - Policy, CDC, Congress, FDA, Orthopedic surgery, Plastic surgery | Leave a comment

Occluding the left atrial appendage to prevent stroke in A-fib

May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

The FDA’s new Breakthrough status for new drug applications

May 24, 2013- Interviewed by Steven E. Greer, MD Janet Woodcock, MD,

Posted in - Pharma, FDA | Leave a comment

FDA official, William Maisel, pleads guilty to crime, keeps job

April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal

Posted in FDA | Leave a comment

Oh my god, I have a disease!

March 21, 2014- This DTC TV drug ad medicalizing a non-disease really struck us as egregious

Posted in - Pharma, Congress, FDA | Leave a comment

The serious adverse events caused by topical testoserone

March 1, 2014

Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA | Leave a comment

FDA investigated by congress for spying on whistleblowers

Update February 26, 2014- Senator Grassley convened an oversight hearing in the senate, and also

Posted in Congress, FDA | Leave a comment

The FDA discusses Brilinta

February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal

Posted in - Pharma, Cardiology, FDA | Leave a comment

The serious adverse events caused by antipsychotics

February 1, 2014

Posted in - Pharma, FDA | Leave a comment

Why the lack of outrage over smoking depicted in film and television?

January 20, 2014 To Senators Dick Durbin, Richard Blumenthal, Sherrod Brown, and Edward Markey

Posted in - Opinion, Congress, FDA | Leave a comment

Laws governing genetic tests

December 19, 2013– Interviewed by Steven E. Greer, MD In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses

Posted in Columbia, Congress, FDA, Genetics | Leave a comment

Google wants your medical records

December 19, 2013- Interviewed by Steven E. Greer, MD In Part 3 of our interview with Robert Klitzman, MD, ethics professor at Columbia University,

Posted in - Biotech, - Policy, Columbia, FDA, Genetics | Leave a comment

TAVI: Comparing CoreValve to Sapien

November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23,  2013- Interviewed by Steven E.  Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer.

Posted in - Medical Devices, Diabetes and endocrinology, FDA | Leave a comment

FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs

Interviewed by Steven E. Greer, MD

Posted in - Pharma, FDA | Leave a comment

Renal denervation devices to treat hypertension

William O’Neill, MD of Henry Ford Hospital discusses renal denervation devices used to treat refractory hypertension. He is involved with the Medtronic device trials.

Posted in - Medical Devices, Cardiology, FDA, Henry Ford | Leave a comment

FDA official, William Maisel, pleads guilty to crime, keeps job

April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal

Posted in - Medical Devices, FDA | Leave a comment